Projects per year
Personal profile
Research Strategic Pillar
Dr. Randall Urban, VP and Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Brain Health
- Specialized Health
- Metabolic Health
- Life Span Health
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Jia Zhou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
5-HT2 Receptor Allosterism in Cocaine Use Disorder
Zhou, J. (PI)
National Institute on Drug Abuse
8/1/22 → 4/30/27
Project: Research project
-
Targeting chemoresistant prostate cancer with novel EED inhibitors
Zhou, J. (PI)
4/1/22 → 3/31/25
Project: Research project
-
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
Zhou, J. (PI)
4/15/21 → 3/31/25
Project: Research project
-
High throughput screening of orthosteric inhibitors of flavivirus protease
Zhou, J. (PI)
1/30/21 → 1/31/25
Project: Research project
-
Chemoprevention of breast cancer by targeting glucose metabolism with HJC0152
Zhou, J. (PI)
Louisiana State University Health Science Center
4/1/20 → 3/31/25
Project: Research project
-
Lessons learnt from broad-spectrum coronavirus antiviral drug discovery
Bolinger, A. A., Li, J., Xie, X., Li, H. & Zhou, J., 2024, In: Expert Opinion on Drug Discovery. 19, 9, p. 1023-1041 19 p.Research output: Contribution to journal › Article › peer-review
-
CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth
Lin, Y., Zhao, Y., Chen, M., Li, Z., Liu, Q., Chen, J., Ding, Y., Ding, C., Ding, Y., Qi, C., Zheng, L., Li, J., Zhang, R., Zhou, J., Wang, L. & Zhang, Q. Q., Dec 2023, In: BMC Cancer. 23, 1, 479.Research output: Contribution to journal › Article › peer-review
Open Access -
Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2)
Ma, Z., Bolinger, A. A., Chen, H. & Zhou, J., Aug 24 2023, In: Journal of medicinal chemistry. 66, 16, p. 10991-11026 36 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018–2022)
Ali, S. & Zhou, J., Aug 5 2023, In: European journal of medicinal chemistry. 256, 115476.Research output: Contribution to journal › Review article › peer-review
Open Access -
Therapeutic potential of salicylamide derivatives for combating viral infections
Xu, J., Xue, Y., Bolinger, A. A., Li, J., Zhou, M., Chen, H., Li, H. & Zhou, J., Jul 2023, In: Medicinal Research Reviews. 43, 4, p. 897-931 35 p.Research output: Contribution to journal › Review article › peer-review
Open Access